Advertisement

Topics

MSD Animal Health to Purchase Manufacturing Facility in Krems, Austria

07:00 EDT 7 Aug 2017 | Merck & Co., Inc.

European Facility Will Boost Global Vaccine Production Capacity

MADISON, N.J.--(BUSINESS WIRE)--MSD Animal Health, known as Merck Animal Health in the United States and Canada, today announced plans to purchase a new manufacturing facility in Krems an der Donau, Austria with the intention to expand its global vaccine manufacturing capacity. The facility, currently owned by Shire plc., was built in 2002 and will add to the company’s impressive global manufacturing capabilities.

Language:
English
Contact:

Merck
Media
Pam Eisele, 267-305-3558
Pamela.eisele@merck.com
or
Noreen Verbrugge, 973-937-5450
Noreen.verbrugge@merck.com
or
Investor Relations
Amy Klug, 908-740-1898
Amy.klug@merck.com

Ticker Slug:
Ticker:
MRK
Exchange:
NYSE

read more

Original Article: MSD Animal Health to Purchase Manufacturing Facility in Krems, Austria

NEXT ARTICLE

More From BioPortfolio on "MSD Animal Health to Purchase Manufacturing Facility in Krems, Austria"

Quick Search
Advertisement
 

Relevant Topic

Merck and Co
Merck & Co is the 7th largest pharmaceutical company in the world based on annual sales, which reached $25,236m in 2009. They have developed 14 vaccines and over 40 prescription products in the major therapeutic areas of cardiovascular disease, respi...